NCT04902729View on ClinicalTrials.gov

Oxytocin vs Carbetocin at Cesarean Delivery in Women With Morbid Obesity

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 20, 2021

Primary Completion Date

December 8, 2022

Study Completion Date

December 9, 2022

Conditions
Post Partum Hemorrhage
Interventions
DRUG

Carbetocin

Patient is given carbetocin (80mcg) intravenously over 1 minute, immediately upon delivery of the anterior shoulder of the baby.

DRUG

Oxytocin

Patient is given oxytocin (1IU) intravenously over 1 minute, immediately upon delivery of the anterior shoulder of the baby, followed by infusion 80 mU/min (40 IU in 1L given at a rate of 120 mL/h).

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT04902729 - Oxytocin vs Carbetocin at Cesarean Delivery in Women With Morbid Obesity | Biotech Hunter | Biotech Hunter